PITTSBURGH (AP) _ NeuBase Therapeutics, Inc. (NBSE) on Thursday reported a loss of $3.8 million in its fiscal third quarter.
The Pittsburgh-based company said it had a loss of 18 cents per share.
NeuBase shares have climbed slightly more than 9% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $7.88, a rise of 52% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBSE at https://www.zacks.com/ap/NBSE
Automated Insights, source Associated Press News